Medical Records

Citation

42 CFR § 2.11

Definitions.

For purposes of the regulations in this part:

Citation

42 CFR § 2.13

Confidentiality restrictions and safeguards.

This provision mandates strict confidentiality for substance use disorder patient records and limits disclosures to those necessary for the intended purpose.

Citation

42 CFR § 2.22

Notice to patients of Federal confidentiality requirements.

This provision mandates that substance use disorder treatment programs provide patients with a formal notice of their privacy practices, legal duties, and patient rights regarding the confidentiality of their records.

Citation

42 CFR § 2.25

Accounting of disclosures.

This provision mandates that part 2 programs provide patients with an accounting of disclosures of their substance use disorder records upon request.

Citation

42 CFR § 2.31

Consent requirements.

This provision specifies the required elements for written consent for the use or disclosure of substance use disorder patient records.

Citation

42 CFR § 2.32

Notice and copy of consent to accompany disclosure.

This provision requires that any disclosure of substance use disorder records made with patient consent must be accompanied by a specific written notice and a copy of the consent.

Citation

42 CFR § 2.52

Scientific research.

This provision establishes the requirements for the use and disclosure of patient identifying information for scientific research, including researcher obligations, IRB approval for data linkages, and data security and retention standards.

Citation

42 CFR § 2.53

Management audits, financial audits, and program evaluation.

This provision establishes the requirements for disclosing patient identifying information from substance use disorder records for the purpose of conducting management audits, financial audits, and program evaluations.